THE ECONOMIC BURDEN OF POSTOPERATIVE THROMBOEMBOLISM OF PULMONARY ARTERY
Author(s)
Bashlakova E1, Vorobiev P2, Krasnova L2
1The First Moscow State Medical University named after I.M. Sechenov, Moscow, Russia, 2Russian Society for Pharmacoeconomics and Outcomes Research, Moscow, Russia
OBJECTIVES: the costs of treatment of patients with pulmonary embolism (PE), which has developed after large surgery and includes the cost of hospital stay, treatment, the cost of medicines, non-drug technologies and rehabilitation. In most studies, cost estimation is performed using a survey of experts and modeling. The objectives of the study were to conduct a cost analysis of patients with PE, which has showed after the operations in "real" practice. METHODS: A retrospective analysis. When analyzing the costs only direct costs were calculated. Total costs were counted by adding costs of medicines, transaction costs, costs of laboratory and instrumental methods of research, medical services, medical staff, costs of hospital stay. RESULTS:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PCV50
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Cardiovascular Disorders